
<!DOCTYPE html>
<html lang="en-US" class=" js">
<head>
<!-- Google tag (gtag.js) -->
<script async src="https://www.googletagmanager.com/gtag/js?id=G-1CD9F90731"></script>
<script>
  window.dataLayer = window.dataLayer || [];
  function gtag(){dataLayer.push(arguments);}
  gtag('js', new Date());

  gtag('config', 'G-1CD9F90731');
</script>


<script async src="https://pagead2.googlesyndication.com/pagead/js/adsbygoogle.js?client=ca-pub-8495225890363177"
     crossorigin="anonymous"></script>
     
 

<link rel="stylesheet" href="https://education-academia.github.io/css/bootstrap.min.css">
<link rel="stylesheet" href="https://education-academia.github.io/css/style.css">
<link rel="stylesheet" href="https://education-academia.github.io/css/custom.css">
<link rel="icon" href="https://education-academia.github.io/images/favicon.png" type="image/x-icon">
<link href="https://cdn.rawgit.com/westonganger/bootstrap-directional-buttons/master/dist/bootstrap-directional-buttons.css" rel="stylesheet" type="text/css">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<meta name="viewport" content="width=device-width, initial-scale=1.0">
<title>The Union Health Ministry has included the use of which anti-viral drug as part of investigational therapy only for restricted emergency-use in its updated Clinical Management Protocol for Covid-19 patients?
</title>
<meta name="description" content="In the protocol, remdesivir is listed as an investigational therapy, i.e. where informed and shared decision making is essential, besides taking note of contra indications mentioned in the detailed guidelines, the ministry said.Remdesivir is an antiviral medicine that works against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). This medicine is to be given only by or under the immediate supervision of your doctor. This product is available in the following dosage forms: Solution.Remdesivir is an inhibitor of the SARS-CoV-2 RNA-dependent RNA polymerase (RdRp), which is essential for viral replication. Remdesivir is an adenosine nucleotide prodrug that is metabolized to the pharmacologically active nucleoside triphosphate metabolite after being distributed into cells.Remdesivir is used to treat COVID-19 infection caused by the SARS-CoV-2 virus. It stops the COVID virus from spreading in the body and causing severe disease.">
<meta name='robots' content='index, follow, max-image-preview:large, max-snippet:-1, max-video-preview:-1'>
<meta name="keywords" content=" What is the drug remdesivir normally used for?, What type of antiviral agent is remdesivir?, What is the role of remdesivir in COVID treatment?, What are other names for remdesivir? ">
</head>
<body data-rsssl="1" class="page-template-default custom-background custom-background-white custom-font-enabled single-author" style="padding: 0px 0px 154px;">
<div id="page" class="site" style="height: auto !important;">
<header id="masthead" class="site-header" role="banner">
<div class="io-title-description">
<a href="https://education-academia.github.io" title="Change your future" rel="home">EDUCATION FOR ALL
</a>
<br>
<a class="site-description">The MCQ hub
</a>
</div>
<nav id="site-navigation" class="themonic-nav" role="navigation">
<a class="assistive-text" href="#main" title="Skip to content">Skip to content
</a>
<ul id="menu-top" class="nav-menu">
<li id="menu-item-695195" class="menu-item menu-item-type-custom menu-item-object-custom menu-item-home menu-item-695195">
<a href="https://education-academia.github.io/">Home
</a>
</li>
</ul>
<select class="selectnav" id="selectnav1">
<option value="">Menu
</option>
<option value="https://education-academia.github.io">HOME
</option>
</select>
</nav>
<!-- #site-navigation -->
<div class="clear">
</div>
</header>
<!-- #masthead -->
<div id="main" class="wrapper">
<div id="primary" class="site-content">
<div id="content" role="main">
<article id="post-1014223" class="post-1014223 page type-page status-publish hentry">
<header class="entry-header">
<h1 class="entry-title"> CURRENT AFFAIRS
</h1>
</header>
<div class="entry-content">
<div class="f-l">
<a href="https://education-academia.github.io/current-affairs/2020/who-is-the-head-of-9-member-working-group-to-suggest-insurance-products-covering-risks-involved-in-the-use-of-remotely-piloted-aircraft-systemrpas-drones-formulated-by-irdai.html" class="btn btn-info btn-arrow-left" role="button" aria-pressed="true">Previous
</a>
</div>
<div class="f-r">
<a href="https://education-academia.github.io/current-affairs/2020/who-launched-the-kapu-nestham-scheme-to-provide-financial-support-of-rs-75000-for-a-period-of-5-year-rs-15000-per-annum-to-women-of-kapu-community.html" class="btn btn-info btn-arrow-right" role="button" aria-pressed="true">Next
</a>
</div>
<div style="text-align:center">
<h2>2020 
</h2>
<h3>
</h3>
<p style="text-align: center;">
<a href="https://drive.google.com/drive/folders/1JxfIMvv4AW-4Jl_pC6NHChgZJETuMZiE?usp=share_link" target="_blank" rel="noopener">
<span style="color: #008000;">
<strong>DOWNLOAD FREE PDF BOOK (USEFUL FOR TEACHERS/INSTRUCTORS/COACHING INSTITUTES)
</strong>
</span>
<span style="color: #ff0000;">
<img src="https://education-academia.github.io/download.gif">
</span>
</a>
</p>
</div>
<strong> The Union Health Ministry has included the use of which anti-viral drug as part of “investigational therapy” only for restricted emergency-use in its updated Clinical Management Protocol for Covid-19 patients? 
</strong>
<p>(A) Trizivir 
</p>
<p>(B) Peramivir 
</p>
<p>(C) ** Remdesivir 
</p>
<p>(D) Indinavir 
</p>
<p>
<div style ="text-align:center">
<h3>EXPLANATIONS BELOW
</h3>
</div>
<p>
<strong>Concept note-1:
</strong>-In the protocol, remdesivir is listed as an investigational therapy, i.e. where informed and shared decision making is essential, besides taking note of contra indications mentioned in the detailed guidelines, the ministry said.
</p>
<p>
<strong>Concept note-2:
</strong>-Remdesivir is an antiviral medicine that works against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). This medicine is to be given only by or under the immediate supervision of your doctor. This product is available in the following dosage forms: Solution.
</p>
<p>
<strong>Concept note-3:
</strong>-Remdesivir is an inhibitor of the SARS-CoV-2 RNA-dependent RNA polymerase (RdRp), which is essential for viral replication. Remdesivir is an adenosine nucleotide prodrug that is metabolized to the pharmacologically active nucleoside triphosphate metabolite after being distributed into cells.
</p>
<p>
<strong>Concept note-4:
</strong>-Remdesivir is used to treat COVID-19 infection caused by the SARS-CoV-2 virus. It stops the COVID virus from spreading in the body and causing severe disease. 
<div class="f-l">
<a href="https://education-academia.github.io/current-affairs/2020/who-is-the-head-of-9-member-working-group-to-suggest-insurance-products-covering-risks-involved-in-the-use-of-remotely-piloted-aircraft-systemrpas-drones-formulated-by-irdai.html" class="btn btn-info btn-arrow-left" role="button" aria-pressed="true">Previous
</a>
</div>
<div class="f-r">
<a href="https://education-academia.github.io/current-affairs/2020/who-launched-the-kapu-nestham-scheme-to-provide-financial-support-of-rs-75000-for-a-period-of-5-year-rs-15000-per-annum-to-women-of-kapu-community.html" class="btn btn-info btn-arrow-right" role="button" aria-pressed="true">Next
</a>
</div>
<p style="text-align: center;">
<a href="https://play.google.com/store/books/author?id=Narayan+Changder" target="_blank" rel="noopener">
<span style="color: #008000;">
<strong>BUY E-BOOK WITH ANSWER KEYS GIVEN AT THE END OF EVERY PAGE
</strong>
</span>
<span style="color: #ff0000;">
<img src="https://education-academia.github.io/buynow.webp">
</span>
</a>
</p>
</div>
<!-- .entry-content -->
<footer class="entry-meta">
</footer>
<!-- .entry-meta -->
</article>
<!-- #post -->
<div id="comments" class="comments-area">
</div>
<!-- #comments .comments-area -->
</div>
<!-- #content -->
</div>
<!-- #primary -->
<div id="secondary" class="widget-area" role="complementary">
<aside id="search-3" class="widget widget_search">
<ul>
<li>
<a href="https://education-academia.github.io/current-affairs/2016/1.html">
<strong>CURRENT AFFAIRS-2016
</strong>
</a>
</li>
<li>
<a href="https://education-academia.github.io/current-affairs/2017/1.html">
<strong>CURRENT AFFAIRS-2017 
</strong>
</a>
</li>
<li>
<a href="https://education-academia.github.io/current-affairs/2018/1.html">
<strong>CURRENT AFFAIRS-2018 
</strong>
</a>
</li>
<li>
<a href="https://education-academia.github.io/current-affairs/2019/1.html">
<strong>CURRENT AFFAIRS-2019 
</strong>
</a>
</li>
<li>
<a href="https://education-academia.github.io/current-affairs/2020/1.html">
<strong>CURRENT AFFAIRS-2020 
</strong>
</a>
</li>
<li>
<a href="https://education-academia.github.io/current-affairs/2021/1.html">
<strong>CURRENT AFFAIRS-2021 
</strong>
</a>
</li>
<li>
<a href="https://education-academia.github.io/current-affairs/2022/1.html">
<strong>CURRENT AFFAIRS-2022 
</strong>
</a>
</li>
<li>
<a href="https://education-academia.github.io/current-affairs/2023/1.html">
<strong>CURRENT AFFAIRS-2023 
</strong>
</a>
</li>
<li>
<a href="https://education-academia.github.io/current-affairs/2024/1.html">
<strong>CURRENT AFFAIRS-2024 
</strong>
</a>
</li>
<li>
<a href="https://education-academia.github.io/current-affairs/2025/1.html">
<strong>CURRENT AFFAIRS-2025
</strong>
</a>
</li>
<li>
<a href="https://education-academia.github.io/current-affairs/2026/1.html">
<strong>CURRENT AFFAIRS-2026
</strong>
</a>
</li>
<li>
<a href="https://education-academia.github.io/current-affairs/2027/1.html">
<strong>CURRENT AFFAIRS-2027
</strong>
</a>
</li>
<li>
<a href="https://education-academia.github.io/current-affairs/2028/1.html">
<strong>CURRENT AFFAIRS-2028 
</strong>
</a>
</li>
<li>
<a href="https://education-academia.github.io/current-affairs/2029/1.html">
<strong>CURRENT AFFAIRS-2029 
</strong>
</a>
</li>
<li>
<a href="https://education-academia.github.io/current-affairs/2030/1.html">
<strong>CURRENT AFFAIRS-2030 
</strong>
</a>
</li>
<li>
<a href="https://education-academia.github.io/current-affairs/miscellaneous/1.html">
<strong>CURRENT AFFAIRS-MISCELLANEOUS 
</strong>
</a>
</li>
</ul>
</aside>
</div>
<!-- #secondary -->
</div>
<!-- #main .wrapper -->
<footer id="colophon" role="contentinfo">
<div class="site-info">
<div class="footercopy">
</div>
<div class="footercredit">
</div>
<div class="clear">
</div>
</div>
<!-- .site-info -->
</footer>
<!-- #colophon -->
<div class="site-wordpress">
</div>
<!-- .site-info -->
<div class="clear">
</div>
</div>
<!-- #page -->
<script src="https://education-academia.github.io/js/jquery.min.js">
</script>
<script src="https://education-academia.github.io/js/bootstrap.min.js">
</script>
</body>
</html>